| Product Code: ETC9515497 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Major Depressive Disorder Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Major Depressive Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Major Depressive Disorder Market - Industry Life Cycle |
3.4 Suriname Major Depressive Disorder Market - Porter's Five Forces |
3.5 Suriname Major Depressive Disorder Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Suriname Major Depressive Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and destigmatization of mental health issues in Suriname |
4.2.2 Rising prevalence of major depressive disorder cases in Suriname |
4.2.3 Growing availability and accessibility of mental health services in the country |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources for mental health treatment in Suriname |
4.3.2 Societal and cultural barriers leading to underreporting and underdiagnosis of major depressive disorder in the population |
5 Suriname Major Depressive Disorder Market Trends |
6 Suriname Major Depressive Disorder Market, By Types |
6.1 Suriname Major Depressive Disorder Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Suriname Major Depressive Disorder Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Suriname Major Depressive Disorder Market Revenues & Volume, By Auvelity (Bupropion/dextromethorphan), 2021- 2031F |
6.1.4 Suriname Major Depressive Disorder Market Revenues & Volume, By Lexapro (Escitalopram), 2021- 2031F |
6.1.5 Suriname Major Depressive Disorder Market Revenues & Volume, By Paxil (Paroxetine), 2021- 2031F |
6.1.6 Suriname Major Depressive Disorder Market Revenues & Volume, By Zoloft (Sertraline), 2021- 2031F |
6.1.7 Suriname Major Depressive Disorder Market Revenues & Volume, By Viibryd (Vilazodone), 2021- 2031F |
6.1.8 Suriname Major Depressive Disorder Market Revenues & Volume, By SEP-363856, 2021- 2031F |
6.1.9 Suriname Major Depressive Disorder Market Revenues & Volume, By REL-1017, 2021- 2031F |
6.1.10 Suriname Major Depressive Disorder Market Revenues & Volume, By REL-1017, 2021- 2031F |
7 Suriname Major Depressive Disorder Market Import-Export Trade Statistics |
7.1 Suriname Major Depressive Disorder Market Export to Major Countries |
7.2 Suriname Major Depressive Disorder Market Imports from Major Countries |
8 Suriname Major Depressive Disorder Market Key Performance Indicators |
8.1 Number of mental health professionals per capita in Suriname |
8.2 Percentage increase in government spending on mental health programs and services |
8.3 Rate of utilization of mental health services by individuals with major depressive disorder |
9 Suriname Major Depressive Disorder Market - Opportunity Assessment |
9.1 Suriname Major Depressive Disorder Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Suriname Major Depressive Disorder Market - Competitive Landscape |
10.1 Suriname Major Depressive Disorder Market Revenue Share, By Companies, 2024 |
10.2 Suriname Major Depressive Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here